Roger Humphrey is executive managing director of JLL Life Sciences.
Labs on the Frontlines: Balancing Re-Entry and the Race to a COVID-19 Cure
How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.
Emerging Life-Sciences Markets: New Partnerships, New Competitors
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.
Global Biopharma Industry Shifts Echoed in Real Estate and Facilities Clusters
Trends in real estate and facility clusters give insight into the state of the biopharmaceutical industry.